Pharmaverse Podcast
In this episode of the Pharmavers Podcast, Michael Pietrack sits down with Kelly Gold, Chief Financial Officer of Camp4 Therapeutics, to discuss her unconventional path from mechanical engineer and competitive dancer to biotech CFO. Kelly shares how designing Biosafety Level 4 laboratories taught her to identify risks, eliminate single points of failure, and develop contingency plans that now guide her financial leadership. She also explains why engineers often make exceptional business leaders and how competitive dance helped shape her resilience, adaptability, and executive presence. The conversation dives into one of the biggest questions facing the life sciences industry today: Why has biotech experienced a prolonged market downturn since the pandemic, and are we finally seeing signs of recovery? Kelly offers a CFO's perspective on capital flows, investor sentiment, M&A activity, IPO markets, and what "normal" might look like for biotech moving forward. You'll also hear practical leadership advice that managers can implement immediately, including why senior leaders should talk less in meetings and create more space for their teams to contribute. Key topics include: • Leadership lessons from competitive dance • Engineering principles applied to financial leadership • Managing risk in biotech and public companies • The biotech funding slowdown and market recovery outlook • Transitioning from private company to public company CFO • Building trust across legal, IP, finance, and business development teams • Women in executive leadership • Balancing family life and C-suite responsibilities • Camp4 Therapeutics' upcoming clinical milestones Whether you're a biotech executive, aspiring leader, investor, or industry professional, this episode offers valuable insights on leadership, resilience, and navigating uncertainty in today's life sciences landscape.
60 jaksot
Kommentit
0Ole ensimmäinen kommentoija
Rekisteröidy nyt ja liity Pharmaverse Podcast-yhteisöön!